Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modulation of fluorouracil by methotrexate, leucovorin, and cisplatin (M-FLP) in the treatment of advanced pancreatic cancer: a phase II study of the Italian Oncology Group for Clinical Research (GOIRC).
Di Costanzo F, Canaletti R, Sdrobolini A, Olmeo N, Luppi G, Pucci F, Cavicchi F, Gasperoni S, Rodinò C, Zironi S, Angiona S, Contu A. Di Costanzo F, et al. Among authors: zironi s. Am J Clin Oncol. 2000 Jun;23(3):314-8. doi: 10.1097/00000421-200006000-00022. Am J Clin Oncol. 2000. PMID: 10857901 Clinical Trial.
Urinary neopterin in malignant lymphoma.
Piccinini L, Zironi S, Federico M, Pini LA, Luppi G. Piccinini L, et al. Among authors: zironi s. Int J Biol Markers. 1991 Oct-Dec;6(4):231-6. doi: 10.1177/172460089100600403. Int J Biol Markers. 1991. PMID: 1795130
Preliminary report of high dose folinic acid and 5-fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research.
Di Costanzo F, Malacarne P, Zironi S, Marzola M, Cornia E, Figoli F, Bacchi M, Passalacqua R, Algeri R, Bartolucci R. Di Costanzo F, et al. Among authors: zironi s. J Surg Oncol Suppl. 1991;2:137-40. doi: 10.1002/jso.2930480529. J Surg Oncol Suppl. 1991. PMID: 1892522 Clinical Trial. No abstract available.
Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
Cocconi G, Bella M, Zironi S, Algeri R, Di Costanzo F, De Lisi V, Luppi G, Mazzocchi B, Rodinò C, Soldani M, et al. Cocconi G, et al. Among authors: zironi s. J Clin Oncol. 1994 Dec;12(12):2687-93. doi: 10.1200/JCO.1994.12.12.2687. J Clin Oncol. 1994. PMID: 7989945 Clinical Trial.
High-dose folinic acid and fluorouracil with or without ifosfamide is an inactive combination in advanced pancreatic cancer. A randomized phase II study of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
Di Costanzo F, Tagliaventi M, Carlini P, Zironi S, Mazzocchi B, Bella M, Donati D, Acito L, Maggian P, Angiona S. Di Costanzo F, et al. Among authors: zironi s. Am J Clin Oncol. 1996 Jun;19(3):307-10. doi: 10.1097/00000421-199606000-00021. Am J Clin Oncol. 1996. PMID: 8638548 Clinical Trial.
High-dose folinic acid and 5-fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research.
Di Costanzo F, Gasperoni S, Malacarne P, Belsanti V, Luppi G, Marzola M, Corgna E, Sdrobolini A, Passalacqua R, Figoli F, Algeri R, Zironi S, Angiona S, Boni C. Di Costanzo F, et al. Among authors: zironi s. Am J Clin Oncol. 1998 Aug;21(4):369-75. doi: 10.1097/00000421-199808000-00011. Am J Clin Oncol. 1998. PMID: 9708636 Clinical Trial.
Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma.
Cocconi G, Carlini P, Gamboni A, Gasperoni S, Rodinò C, Zironi S, Bisagni G, Porrozzi S, Cognetti F, Di Costanzo F, Canaletti R, Ruggeri EM, Camisa R, Pucci F; Italian Oncology Group for Clinical Research. Cocconi G, et al. Among authors: zironi s. Ann Oncol. 2003 Aug;14(8):1258-63. doi: 10.1093/annonc/mdg329. Ann Oncol. 2003. PMID: 12881389 Free article. Clinical Trial.
Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Bertolini F, Bengala C, Losi L, Pagano M, Iachetta F, Dealis C, Jovic G, Depenni R, Zironi S, Falchi AM, Luppi G, Conte PF. Bertolini F, et al. Among authors: zironi s. Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1455-61. doi: 10.1016/j.ijrobp.2007.02.018. Epub 2007 Apr 18. Int J Radiat Oncol Biol Phys. 2007. PMID: 17445998
Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
Di Costanzo F, Gasperoni S, Manzione L, Bisagni G, Labianca R, Bravi S, Cortesi E, Carlini P, Bracci R, Tomao S, Messerini L, Arcangeli A, Torri V, Bilancia D, Floriani I, Tonato M; Italian Oncology Group for Cancer Research; Dinota A, Strafiuso G, Corgna E, Porrozzi S, Boni C, Rondini E, Giunta A, Monzio Compagnoni B, Biagioni F, Cesari M, Fornarini G, Nelli F, Carboni M, Cognetti F, Enzo MR, Piga A, Romiti A, Olivetti A, Masoni L, De Stefanis M, Dalla Mola A, Camera S, Recchia F, De Filippis S, Scipioni L, Zironi S, Luppi G, Italia M, Banducci S, Pisani Leretti A, Massidda B, Ionta MT, Nicolosi A, Canaletti R, Biscottini B, Grigniani F, Di Costanzo F, Rovei R, Croce E, Carroccio R, Gilli G, Cavalli C, Olgiati A, Pandolfi U, Rossetti R, Natalini G, Foa P, Oldani S, Bruno L, Cascinu S, Catalano G, Catalano V, Lungarotti F, Farris A, Sarobba MG, Trignano M, Muscogiuri A, Francavilla F, Figoli F, Leoni M, Papiani G, Orselli G, Antimi M, Bellini V, Cabassi A, Contu A, Pazzola A, Frignano M, Lastraioli E, Saggese M, Bianchini D, Antonuzzo L, Mela M, Camisa R. Di Costanzo F, et al. Among authors: zironi s. J Natl Cancer Inst. 2008 Mar 19;100(6):388-98. doi: 10.1093/jnci/djn054. Epub 2008 Mar 11. J Natl Cancer Inst. 2008. PMID: 18334706 Clinical Trial.
21 results